Thursday, May 23, 2013 Last update: 4:07 AM
Company Tech News as it Breaks
DelMar Pharmaceuticals
News articles for DelMar Pharmaceuticals:
Monday, March 11, 2013
- DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock ConferenceVANCOUVER, British Columbia and MENLO PARK, Calif., March 11, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar"), a clinical and commercial stage drug development company with a focus on the treatment of cancer, today announced that Jeffrey Bacha, President & CEO of DelMar, will present at ... read more
Friday, January 25, 2013
- DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer TherapiesVANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 25, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: BRRY) ("DelMar") today announced the successful acquisition (the "Acquisition"), through a share exchange agreement, of all of the outstanding shares of Del Mar Pharmaceuticals (BC) Ltd., a clinical and commercial stage ... read more